Leadership

Unparalleled Expertise Guiding the Revolution in Programmable Medicines

LeadershipBoard of DirectorsAdvisory Team

Leadership

Tuyen Ong, MD, MBA

Chief Executive Officer, Ring Therapeutics & CEO Partner, Flagship Pioneering

Tuyen_large-headshot@2x

Yong S. Chang, PhD

Chief Scientific Officer

Yong_large-headshot@2x

Christopher Wright, MD, PhD

Chief Medical Officer, Head of Translational Research

wright_smile1_crop-CIRCLE

Christopher McNulty

Chief Financial Officer, Head of Corporate Strategy

CMcnulty Headshot-correction-circle

Yuko Soneoka Gee, PhD, JD

VP, Intellectual Property

Yuko_large-headshot@2x-rev

Anne Osborne, MS

Executive Director, Program Management

Anne_large-headshot_2x

Megan Woods, MBA

SVP, Head of Human Resources

Megan_large-headshot@2x

Board of Directors

Tuyen Ong, MD, MBA

CEO, Ring Therapeutics; CEO Partner, Flagship Pioneering

Avak Kahvejian, PhD

Founder, Ring Therapeutics; Chairman of Board of Directors, Ring Therapeutics; Partner, Flagship Pioneering

Francois Nader, MD, MBA

Former CEO, NPS Pharma

B. Lynne Parshall, Esq

Strategic Advisor and Former COO, Ionis Pharmaceuticals

Hari Pujar, PhD, MBA

COO, Tessera Therapeutics, Operating Partner, Flagship Pioneering

Advisory Team

Kristian Andersen, PhD

Professor, Scripps Research

Aravind Asokan, PhD

Professor and Director of Gene Therapy, Duke University

Hildegund Ertl, MD

Professor, Vaccine & Immunotherapy Center, Wistar Institute Vaccine Center

Don Ganem, MD

Professor Emeritus, University of California San Francisco; Former Global Head of Infectious Diseases, Novartis Institutes for BioMedical Research (NIBR)

Guangping Gao, PhD

Professor & Director of Horae Gene Therapy Center and Viral Vector Core, UMass Medical School

Mark Kay, MD, PhD

Professor, Stanford University